Skip to main content
OpenTrials
Completed

NCT Number: NCT06284148

Confidential IPV Screening Tool

Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–49 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Biomedical Informatics Center

Charleston, South Carolina, 29403, United States

About this study

The objective of this study was to develop and evaluate an integrated suite of electronic health record (EHR) tools that automates "best practices" from Northern California Kaiser Permanente for screening and intervention for IPV identified within clinical settings. The goal of the intervention goes beyond mere screening of patients for IPV and includes tools for assessment of IPV risk, for documentation of IPV care, and support for a warm hand-off during the primary care visit to a national IPV hotline resource. Importantly, the study includes work to keep notes documenting IPV and billing for IPV care confidential, segmenting this care in a secure segment of the electronic health record.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being an Medical University of South Carolina patient at primary care clinics (family medicine)
  • Women 18-49 years of age inclusive
  • Reported yes to wanting to be contacted for a follow-up research study
  • English-speaking

Exclusion criteria

  • No exclusion criteria

Treatment and study plan

Screening for intimate partner violence

Diagnostic Test

confidential screening using exam computer

Assessment and referral

Other

confidential assessment and referral of high-risk patients using decision-support templates

Primary outcomes

  1. IPV positive (Yes/No)

    Time frame: 29 months

    Depending on patient's answers to screening questions, they are flagged as either IPV positive or negative

  2. Screening completed (Yes/No)

    Time frame: 29 months

    Whether the assigned screening was completed during patient visit

Secondary outcomes

  1. Severity of risk

    Time frame: 29 months

    using Danger 5 risk assessment, ranging from 0 to 5

  2. Physician compliance with IPV management tools

    Time frame: 29 months

    Measured as the rate of completion of follow-up decision templates, and the rate of referrals for post-visit counseling to a national hotline (a share from screened positive patients

Sponsors and collaborators

Lead sponsor

Medical University of South Carolina

Other

Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

Registry information

Official study title

EHR-based Screening and Intervention for Intimate Partner Violence

Important dates

Study start
2010
Primary completion
2023
Study completion
2023
First posted
Feb 28, 2024
Registry last updated
Feb 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.